David Stover

Founder, CEO & Board Member at Nammi Therapeutics

Dr. Stover has over 25 years of experience in both small molecule and biologics drug discovery and development at Agensys/Astellas, Novartis, MDS Proteomics, Kinetix Pharmaceuticals, and Ciba-Geigy.

Dr. Stover is an accomplished drug developer having been directly involved in 15 INDs, 8 of which reached clinical Proof of Concept so far. He earned his Ph.D. in Biochemistry at the University of Washington and holds a B.S. in Zoology from Duke University.


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Nammi Therapeutics

Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.


Employees

1-10

Links